Transforming growth factor β inhibits growth of more differentiated myeloid leukemia cells and retinoblastoma protein phosphorylation at serine 795

Experimental Hematology

Volumn 27, Issue 4, 1999, Pages 605-614

  Hu, Xiaotang ^a   Moscinski, Lynn C ^a   Zuckerman, Kenneth S ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Cell cycle; Myeloid leukemic cells; pRb; Progenitor; Transforming growth factor

Indexed keywords

RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 3; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; RETINOBLASTOMA PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; COLONY FORMING UNIT; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOMODULATION; MYELOID LEUKEMIA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

CELL DIFFERENTIATION; CELL DIVISION; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LEUKEMIA, MYELOID; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS; RETINOBLASTOMA PROTEIN; S PHASE; SERINE; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 0032929017     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(99)00004-1     Document Type: Article

References (40)

1. Shipley G.D., Tucker R.F., Moses H.L. Type β transforming growth factor/growth inhibitor stimulates entry of monolayer cultures of AKR-2B cells into S phase after a prolonged prereplicative interval. Proc Natl Acad Sci U S A. 82:1985;4147.
2. Tucker R.F., Shipley G.D., Moses H.L., Holley R.W. Growth inhibitor from BSC-1 cells closely related to platelet type β transforming growth factor. Science. 226:1985;705.
3. Moses H.L., Tucker R.F., Leof E.B., Coffey R.J. Jr., Halper J., Shipley G.D. Type-β transforming growth factor is a growth stimulator and a growth inhibitor. Cancer Cells. 3:1985;65.
4. Sing G.K., Keller J.R., Ellingsworth L.R., Ruscetti F.W. Transforming growth factor-β selectively inhibits normal and leukemic human bone marrow cell growth in vitro. Blood. 72:1988;1504.
5. Keller J.R., McNiece I.K., Sill K.T., Ellingsworth L.R., Quesenberry P.J., Sing G.K., Ruscetti F.W. Transforming growth factor-β1 directly regulates primitive murine hematopoietic cell proliferation. Blood. 75:1990;596.
6. Ottmann O.G., Pelus L.M. Differential proliferative effects of transforming growth factor-β on human hematopoietic progenitor cells. J Immunol. 140:1991;2661.
7. Snoeck H.-W., Weekx S., Moulijn A., Lardon F., Lenjou M., Nys F., Van Ranst P.C.F., Van Bockstaele D.R., Berneman Z.N. Tumor necrosis factor α is a potent synergistic factor for the proliferation of primitive human hematopoietic progenitor cells and induces resistance to transforming growth factor β but not to interferon γ J Exp Med. 183:1996;705.
8. Keller J.R., Jacobsen S.E.W., Dubois C.M., Hestda I.K., Ruscetti F.W. Transforming growth factor-β a bidirectional regulator of hematopoietic cell growth Int J Cell Cloning. 10:1992;2.
9. Goey H., Keller J.R., Back T., Longo D.L., Ruscetti F.W., Wiltrout R.H. Inhibition of early murine hematopoietic progenitor cell proliferation after in vivo locoregional administration of transforming growth factor-β1. J Immunol. 143:1989;877.
10. Sitnicka E., Ruscetti F.W., Priestley G.V., Wolf N.S., Bartelmez S.H. Transforming growth factor β1 directly and reversibly inhibits the initial cell divisions of long-term repopulating hematopoietic stem cells. Blood. 88:1996;82.
11. Ohta M., Greenherger J.S., Anklesaria P., Bassols A., Massague M. Two forms of transforming growth factor β distinguished by multipotential hematopoietic progenitor cells. Nature. 329:1987;539.
12. Keller J.R., Bartelmez S.H., Sitnicka E., Ruscetti F.W., Ortiz M., Gooya J.M., Jacobsen S.E.W. Distinct and overlapping direct effects of macrophage inflammatory protein-1α and transforming growth factor β on hematopoietic progenitor/stem cell growth. Blood. 84:1994;2175.
13. McNiece I.K., Bertoncello I., Keller J.R., Ruscetti F.W., Hartley C.A., Zsebo K.M. Transforming growth factor β inhibits the action of stem cell factor on mouse and human hematopoietic progenitors. Int J Cell Cloning. 10:1992;80.
14. Keller J.R., Jacobsen S.E.W., Sill K., Ellingsworth L., Ruscetti F.W. Stimulation of granulopoiesis by transforming growth factor β synergy with granulocyte-macrophage colony-stimulating factor Proc Natl Acad Sci U S A. 88:1991;7190.
15. Aglietta M., Stacchini A., Severino A., Sanavio F., Ferrando M.L., Piacibello W. Interaction of transforming growth factor-beta with hematopoietic growth factors in the regulation of human normal and leukemic myelopoiesis. Exp Hematol. 17:1989;296.
16. Cashman J.D., Eaves A.C., Eaves C.J. Granulocyte-macrophage colony-stimulting factor modulation of the inhibitory effect of transforming growth factor-β on normal and leukemic human hematopoietic progenitor cells. Leukemia. 6:1992;886.
17. Murohashi I., Endho K., Nishida S., Yoshida S., Jinnai I., Bessho M., Hirashima K. Differential effects of TGF-β1 on normal and leukemic human hematopoietic cell proliferation. Exp Hematol. 23:1995;970.
18. Kanatni Y., Kasukabe T., Okabe-Kado J., Hayashi S.I., Yamamoto-Yamaguchi Y., Motoyoshi K., Nagata N., Honma Y. Transforming growth factor β and dexamethasone cooperatively enhance c-jun gene expression and inhibit the growth of human monocytoid leukemia cells. Cell Growth Differ. 7:1996;187.
19. Furukawa Y., Uenoyama S., Ohta M., Tsunoda A., Griffin J.D., Saito M. Transforming growth fctor-β inhibits phosphorylation of the retinoblastoma susceptibility gene product in human monocytic leukemia cell line JOSK-I. J Biol Chem. 267:1992;17121.
20. Kitamura T., Tange T., Terasawa T., Chiba S., Kuwaki T., Miyagawa K., Piao Y.-F., Miyazonno K., Urabe A., Takaku F. Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J Cell Physiol. 140:1989;323.
21. Koeffler H.P., Golde D.W. Acute myelogenous leukemia. a human cell line responsive to colony-stimulating activity Science. 200:1978;1153.
22. Koeffler H.P., Billing R., Lusis A.J., Sparkes R., Golde D.W. An undifferentiated variant derived from the human acute myelogenous leukemia cell line (KG-1). Blood. 56:1980;265.
23. Lange B., Valtieri M., Santoli D., Caracciolo D., Mavilio F., Gemperlein I., Griffin C., Emanuel B., Finan J., Nowell P., Rovera G. Growth factor requirements of childhood acute leukemia. establishment of GM-CSF-dependent cell lines Blood. 70:1987;192.
24. Avancd G.C., Lista P., Giovinazzo B., Miniero R., Saglio G., Benetton G., Coda R., Catoretti G., Pegoraro P. Selective growth response to IL-3 of a human leukemic cell line with megakaryoblastic features. Br J Haematol. 69:1988;359.
25. Martin P., Papayannopoulou T. HEL cells. a new human erythroleukemia cell line with spontaneous and induced globin expression Science. 216:1982;1233.
26. Hu X., Moscinski L.C., Hill B.J., Fisher A.B., Zuckerman K.S. Characterization of a unique factor-independent variant derived from human factor-dependent TF-1 cells. a transformed event Leukemia Res. 22:1998;817.
27. Bouchard C., Fridman W.H., Sautès C. Effect of TGF-β1 on cell cycle regulatory proteins in LPs-stimulated normal mouse B lymphocytes. J Immunol. 159:1997;4155.
28. Sumegi J., Uzrolgyi E., Klein G. Expression of the RB gene under the control of MuLv-LTR suppresses tumorigenicity of WERI-Rb-27 retinoblasoma cells in immunodefective mice. Cell Growth Differ. 1:1990;247.
29. Sherr C.J. The ins and outs of RB. coupling gene expression to the cell cycle clock Trends Cell Biol. 4:1994;15.
30. Laiho M., deCaprio J.A., Ludlow J.W., Livingston D.M., Massague J. Growth inhibition by TGFβ linked to suppression of retinoblastoma protein phosphorylation. Cell. 62:1990;175.
31. Ewen M.E., Sluss H.K., Whitehouse L.L., Livingston D.M. TGFβ inhibition of Cdk4 synthesis is linked to cell cycle arrest. Cell. 74:1994;1009.
32. Ezhevsky S.A., Nagahara H., Vocero-Akbani A.M., Gius D.R., Wei M.C., Dowdy S.F. Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb. Proc Natl Acad Sci U S A. 94:1997;10699.
33. 1 cyclins and cyclin-dependent protein kinases. Proc Natl Acad Sci U S A. 90:1993;10315.
34. Pietenpol J.A., Stein R.W., Moran E., Yaciuk P., Schlegel R., Lyons R.M., Pittelkow M.R., Munger K., Howley P.M., Moses H.L. TGF-β1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell. 61:1990;777.
35. Connel-Crowley L., Harper J.W., Goodrich W. Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation. Mol Biol Cell. 8:1997;287.
36. Coffey R.J. Jr., Bascom C.C., Sipes N.J., Graves-Deal R., Weissman B.E., Moses H.L. Selective inhibition of growth-related gene expression in muine keratinocytes by transformaing growth factor β Mol Cell Biol. 8:1988;3088.
37. Shipley G.D., Pittelkow M.R., Willie J.J. Jr., Scott R.E., Moses H.L. Reversible inhibition of normal human prokeratinocyte proliferation by type β transforming growth factor-growth inhibitor in serum-free medium. Cancer Res. 46:1986;2068.
38. Knabble C., Lippman M.E., Wakefield L.M., Flanders K.C., Kasid A., Derynck R., Dickson R.B. Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells. Cell. 48:1987;417.
39. Masui T., Wakefield L.M., Lechner J.F., LaVeck M.A., Sporn M.B., Harris C.C. Type β transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells. Proc Natl Acad Sci U S A. 83:1986;2438.
40. Weinberg R.A. The retinoblastoma protein and cell cycle control. Cell. 81:1995;323.